57806-04-9 Usage
Uses
Used in Organic Synthesis:
1-methyl-1H-imidazo[4,5-b]pyridine-2-carbaldehyde is used as a building block in organic synthesis for the creation of various pharmaceuticals and organic compounds. Its unique structure allows for the development of new molecules with potential therapeutic properties.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1-methyl-1H-imidazo[4,5-b]pyridine-2-carbaldehyde is used as an intermediate in the synthesis of bioactive molecules. Its potential biological activities make it a promising candidate for the development of new drugs.
Used in Drug Target Research:
1-methyl-1H-imidazo[4,5-b]pyridine-2-carbaldehyde is studied for its potential as a drug target. Its interaction with biological systems and potential effects on cellular processes make it a valuable subject for research in drug discovery.
Used in Fluorescent Probe Development:
In the field of biological detection and imaging, 1-methyl-1H-imidazo[4,5-b]pyridine-2-carbaldehyde has been investigated for its potential as a fluorescent probe. Its ability to emit fluorescence upon interaction with biological targets makes it a useful tool for visualizing and studying various biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 57806-04-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,8,0 and 6 respectively; the second part has 2 digits, 0 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 57806-04:
(7*5)+(6*7)+(5*8)+(4*0)+(3*6)+(2*0)+(1*4)=139
139 % 10 = 9
So 57806-04-9 is a valid CAS Registry Number.
57806-04-9Relevant academic research and scientific papers
MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2
-
Page/Page column 74-75, (2021/08/06)
The present application provides a compound of Formula: or a pharmaceutically acceptable salt thereof, wherein ring B, L1, ring A, L2, n, R1, R2, R3, R4, and X1 are as described herein. Pharmaceutical compositions comprising the compound, as well as the methods of making and using the compound, are also provided.
3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: A novel series of mGluR2 positive allosteric modulators
Zhang, Lei,Rogers, Bruce N.,Duplantier, Allen J.,McHardy, Stanley F.,Efremov, Ivan,Berke, Helen,Qian, Weimin,Zhang, Andy Q.,Maklad, Noha,Candler, John,Doran, Angela C.,Lazzaro Jr., John T.,Ganong, Alan H.
scheme or table, p. 5493 - 5496 (2009/06/18)
The synthesis and structure-activity relationship (SAR) of a novel series of 3-(imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers, derived from a high throughput screening (HTS), are described. Subsequent optimization led to identification of potent, metabolically stable and orally available mGluR2 positive allosteric modulators (PAMs).
